Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M204Revenue (TTM) $M50.5Net Margin (%)-10.6Altman Z-Score-2.0
Enterprise Value $M181EPS (TTM) $-0.1Operating Margin %-11.0Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.3Pre-tax Margin (%)-11.0Higher ROA y-yN
Price/Book8.510-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %--Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-420.0ROA % (ttm)-13.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-25.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M41.2ROIC % (ttm)-304.8Gross Margin Increase y-yN

Gurus Latest Trades with CDXS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CDXSGeorge Soros 2011-12-31 Sold Out -0.0012%$4.24 - $6.02
($2.63)
$ 4.9588%Sold Out0
CDXSGeorge Soros 2011-09-30 Buy $4.39 - $10.24
($6.98)
$ 4.95-29%New holding14,800
CDXSGeorge Soros 2010-09-30 Sold Out -0.04%$7.11 - $9.77
($8.46)
$ 4.95-41%Sold Out0
CDXSGeorge Soros 2010-06-30 Buy 0.04%$8.69 - $14.45
($11.75)
$ 4.95-58%New holding153,639
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CDXS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CDXS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Yang Patrick YDirector 2016-11-15Buy10,000$4.832.48view
Vivo Ventures Fund VII, L.P.10% Owner 2016-09-08Sell111,600$4.2516.47view
WOLF DENNIS PDirector 2016-08-29Sell18,000$4.2217.3view
KELLEY BERNARD JDirector 2016-08-24Sell12,643$4.2616.2view
Vivo Ventures Fund VII, L.P.10% Owner 2016-08-16Sell86,894$4.2516.47view
Vivo Ventures Fund VII, L.P.10% Owner 2016-08-04Sell80,000$4.2217.3view
Lalonde JamesSVP, R&D 2015-11-11Sell9,441$3.5240.63view
Yang Patrick YDirector 2015-09-11Buy10,000$3.4742.65view
KELLEY BERNARD JDirector 2015-09-10Sell5,200$3.4543.48view
Yang Patrick YDirector 2015-08-24Buy10,000$3.8428.91view

Quarterly/Annual Reports about CDXS:

News about CDXS:

Articles On GuruFocus.com
Weekly 3-Year Lows Highlight: SEAS, AMTG, AHH, NCTY, CDXS Dec 30 2013 
Weekly CEO Buys Highlight: AKAM, DRC, MDRX, MTG, CDXS Mar 17 2013 
A New Beginning for Codexis? Mar 08 2013 
Weekly CFO Buys Highlight: ASNB, FXCM, CDXS, VTNC, BRS Sep 24 2012 

More From Other Websites
Codexis to Commercially Supply Proprietary Enzyme to Tate & Lyle Dec 06 2016
ETFs with exposure to Codexis, Inc. : December 2, 2016 Dec 02 2016
Codexis Names Pharmaceutical Industry Veteran Bernard J. Kelley Chairman of the Board Dec 01 2016
Codexis Names Pharmaceutical Industry Veteran Bernard J. Kelley Chairman of the Board Dec 01 2016
Codexis, Inc. :CDXS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016 Nov 23 2016
CODEXIS INC Financials Nov 17 2016
Codexis to Present at the 7th Annual Craig-Hallum Alpha Select Conference Nov 10 2016
Edited Transcript of CDXS earnings conference call or presentation 8-Nov-16 9:30pm GMT Nov 09 2016
Codexis beats 3Q profit forecasts Nov 08 2016
Codexis beats 3Q profit forecasts Nov 08 2016
Codexis Reports Financial Results for the Third Quarter of 2016 Nov 08 2016
CODEXIS INC Files SEC form 8-K, Results of Operations and Financial Condition Nov 08 2016
Codexis Reports Financial Results for the Third Quarter of 2016 Nov 08 2016
Q3 2016 Codexis Inc Earnings Release - After Market Close Nov 08 2016
Codexis to Hold 2016 Third Quarter Conference Call on November 8 Nov 01 2016
Codexis to Hold 2016 Third Quarter Conference Call on November 8 Nov 01 2016
CODEXIS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Oct 20 2016
Michael Aldridge Joins Codexis as Senior Vice President, Corporate & Strategic Development Oct 17 2016
Michael Aldridge Joins Codexis as Senior Vice President, Corporate & Strategic Development Oct 17 2016
CODEXIS INC Files SEC form 8-K, Change in Directors or Principal Officers Oct 14 2016
CODEXIS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 05 2016
Codexis Completes Transfer of CodeEvolver® Technology to Merck Oct 05 2016
Codexis Completes Transfer of CodeEvolver® Technology to Merck Oct 05 2016
ETF’s with exposure to Codexis, Inc. : September 29, 2016 Sep 29 2016
ETF’s with exposure to Codexis, Inc. : September 14, 2016 Sep 14 2016
How Codexis (CDXS) Stock Stands Out in a Strong Industry Aug 18 2016
Codexis, Inc. :CDXS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 Aug 15 2016
Edited Transcript of CDXS earnings conference call or presentation 9-Aug-16 8:30pm GMT Aug 10 2016
Codexis beats 2Q profit forecasts Aug 09 2016
Codexis Reports Financial Results for the Second Quarter of 2016 Aug 09 2016
Codexis to Hold 2016 Second Quarter Conference Call on August 9 Aug 02 2016
Codexis Completes Obligations Under Research and Development Agreement with Leading... Jul 28 2016
Codexis to Present at Jefferies 2016 Healthcare Conference Jun 02 2016
Codexis to Present at Upcoming Investment Conferences May 18 2016
Codexis reports 1Q loss May 09 2016
Codexis Reports Financial Results for the First Quarter of 2016 May 09 2016
Codexis to Hold 2016 First Quarter Conference Call on May 9 May 02 2016
Codexis Completes CodeEvolver® Technology Transfer to GSK; Earns $7.5 Million Milestone Payment May 02 2016
Codexis reports 4Q loss Mar 03 2016
Codexis Signs Multi-year Extension of Contract with Merck to Supply Enzyme Used in Manufacture of... Dec 18 2015
Codexis posts 3Q profit Nov 04 2015
Codexis reports 2Q loss Aug 11 2015
Codexis reports 1Q loss May 07 2015
Codexis posts 4Q profit Mar 03 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)